Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Promising Outcome of Imatinib-Combined Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of the Japan Adult Leukemia Study Group (JALSG) Ph+ALL202 Regimen.

Yoshihiro Hatta, Shuichi Mizuta, Shigeki Ohtake, MD, PhD, Isamu Sugiura, MD, PhD, Yasunori Ueda, MD, Heiwa Kanamori, Hideki Akiyama, Makoto Takeuchi, Noriko Usui, Toshiaki Yujiri, Atsushi Fujieda, Toru Kiguchi, MD, Itsuro Jinnai, MD, Tomoki Naoe, MD, PhD, Ryuzo Ohno, MD

Blood (2009) 114 (22): 3090.

https://doi.org/10.1182/blood.V114.22.3090.3090

Published: 2009

Journal Articles

Outcome by Treatment Including An Intensified Consolidation Program with Dose-Escalated Doxorubicin for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL): A Study by the Japan Adult Leukemia Study Group (JALSG ALL97 study).

Itsuro Jinnai, MD, Tohru Sakura, MD, Motohiro Tsuzuki, MD, Yasuhiro Maeda, MD, PhD, Noriko Usui, MD, Masayuki Kato, MD, Hirokazu Okumura, MD, PhD, Yasunori Ueda, MD, Yuji Kishimoto, MD, Fumiharu Yagasaki, MD, Jin Takeuchi, MD, Masako Iwanaga, MD, Yasushi Miyazaki, MD, Shuichi Miyawaki, MD, Kazunori Ohnishi, MD, PhD, Tomoki Naoe, MD, Ph.D., Ryuzo Ohno, MD

Blood (2009) 114 (22): 4334.

https://doi.org/10.1182/blood.V114.22.4334.4334

Published: 2009

Journal Articles

Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation during First Complete Remission Following Imatinib-Combined Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Shuichi Mizuta, Masamitsu Yanada, Isamu Sugiura, Fumiharu Yagasaki, Toshiaki Yujiri, Makoto Takeuchi, Yoshihiro Hatta, Yukihiko Kimura, Yasunori Ueda, MD, Heiwa Kanamori, Noriko Usui, Hideki Akiyama, Yasushi Miyazaki, MD, PhD, Shigeki Ohtake, Itsuro Jinnai, MD, Keitaro Matsuo, Tomoki Naoe, MD, Ryuzo Ohno, MD

Blood (2008) 112 (11): 462.

https://doi.org/10.1182/blood.V112.11.462.462

Published: 2008

Journal Articles

Serum Erythropoietin Dose Not Participate in Anemia That Persists in CML Patients after MMR Achievement by Imatinib Mesylate Therapy

Maho Ishikawa, MD, PhD, Fumiharu Yagasaki, MD, PhD, Daisuke Okamura, MD, Tomoya Maeda, MD, PhD, Naoki Takahashi, MD, PhD, Nobutaka Kawai, MD, PhD, Akira Matsuda, MD, PhD, Itsuro Jinnai, MD, PhD, Masami Bessho, MD, PhD

Blood (2008) 112 (11): 4274.

https://doi.org/10.1182/blood.V112.11.4274.4274

Published: 2008

Journal Articles

Factors Associated with Relapse-Free Survival in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Imatinib-Combined Chemotherapy.

Masamitsu Yanada, MD, Jin Takeuchi, MD, Isamu Sugiura, MD, Hideki Akiyama, MD, Noriko Usui, MD, Fumiharu Yagasaki, MD, Kazuhiro Nishii, MD, Yasunori Ueda, MD, Makoto Takeuchi, MD, Shuichi Miyawaki, MD, Atsuo Maruta, MD, Hiroto Narimatsu, MD, Yasushi Miyazaki, MD, Shigeki Ohtake, MD, Itsuro Jinnai, MD, Keitaro Matsuo, MD, Tomoki Naoe, MD, Ryuzo Ohno, MD

Blood (2007) 110 (11): 2813.

https://doi.org/10.1182/blood.V110.11.2813.2813

Published: 2007

Journal Articles

High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia.

Masamitsu Yanada, MD, Jin Takeuchi, MD, Isamu Sugiura, MD, Hideki Akiyama, MD, Noriko Usui, MD, Fumiharu Yagasaki, MD, Nobuhiko Emi, MD, Yasushi Miyazaki, MD, Shigeki Ohtake, MD, Itsuro Jinnai, MD, Keitaro Matsuo, MD, Tomoki Naoe, MD, Ryuzo Ohno, MD

Blood (2005) 106 (11): 1827.

https://doi.org/10.1182/blood.V106.11.1827.1827

Published: 2005

Journal Articles

Recommended Repeated Intrathecal Ara-C/MTX/PDN Injections during Rituximab-Based Therapy for B-Cell Lymphoma.

Daisuke Wakao, MD, PhD, Toshiya Suzuki, MD, PhD, Katsuro Ito, MD, PhD, Katsuhiko Yoshida, MD, PhD, Itsuro Jinnai, MD, PhD, Masami Bessho, MD, PhD

Blood (2005) 106 (11): 4720.

https://doi.org/10.1182/blood.V106.11.4720.4720

Published: 2005

Journal Articles

Expression of ERK1/ERK2 MAP Kinase, Protein Kinase C and Akt Kinase by Lymphoid Malignant Cells.

Ikuo Murohashi, MD, Takashi Takahashi, MD, Noriko Ihara, MS, Daisuke Wakao, MD, Fumiharu Yagasaki, MD, Yhuichi Nakamura, MD, Nobutaka Kawai, MD, Akira Matsuda, MD, Itsuro Jinnai, MD, Masami Bessho, MD

Blood (2005) 106 (11): 4391.

https://doi.org/10.1182/blood.V106.11.4391.4391

Published: 2005

NARROW

Promising Outcome of Imatinib-Combined Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of the Japan Adult Leukemia Study Group (JALSG) Ph+ALL202 Regimen.

Outcome by Treatment Including An Intensified Consolidation Program with Dose-Escalated Doxorubicin for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL): A Study by the Japan Adult Leukemia Study Group (JALSG ALL97 study).

Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation during First Complete Remission Following Imatinib-Combined Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Serum Erythropoietin Dose Not Participate in Anemia That Persists in CML Patients after MMR Achievement by Imatinib Mesylate Therapy

Factors Associated with Relapse-Free Survival in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Imatinib-Combined Chemotherapy.

High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia.

Recommended Repeated Intrathecal Ara-C/MTX/PDN Injections during Rituximab-Based Therapy for B-Cell Lymphoma.

Expression of ERK1/ERK2 MAP Kinase, Protein Kinase C and Akt Kinase by Lymphoid Malignant Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only